Search

everythinglearnresearchcommunity

for

Search:↓

Most patients with frontal fibrosing alopecia had facial bumps, with Hispanic/Latino and premenopausal women being more affected, suggesting a more severe condition.

The environment around the time of conception can change the VTRNA2-1 gene in a way that lasts for years and may affect disease risk.

The conference highlighted new dermatological treatments and emphasized early intervention and addressing conditions lacking evidence-based treatments.

A rare scalp condition causing hair loss improved with a specific cream.

Skin problems are common in lupus, important for diagnosis, and can be triggered by sunlight.

Hormones significantly affect women's sexual function, and more research is needed to improve treatments for sexual dysfunction with minimal side effects.

Long-haul COVID can cause lasting symptoms affecting many body systems and may be linked to ongoing inflammation and immune system issues.

Tofacitinib may slow hair loss in scarring alopecias but is unlikely to regrow significant hair.

Non-invasive methods show promise for diagnosing skin diseases like psoriasis and lupus but need more research for regular use.

New drugs for rheumatoid arthritis show improvement but have side effects and are not a cure.

An imbalance between certain immune cells is linked to a chronic skin condition and may be influenced by obesity, smoking, and autoimmune issues.

17-β-Estradiol applied to the skin stops hair growth, while ICI 182 780 helps hair grow in mice.

New protein changes may be involved in the immune attack on hair follicles in alopecia areata.

Alopecia areata involves immune activation in the scalp, suggesting treatments targeting TH1, TH2, and IL-23 pathways.

Exosomes can improve skin health and offer new treatments for skin repair and rejuvenation.

Scientists have created a new hair loss treatment using ultrasound to deliver gene-editing particles, which resulted in up to 90% hair regrowth in mice.

Hair loss treatments include medications and new methods like low-level light therapy, which may work by boosting cell activity and blood flow.

Alopecia areata causes hair loss due to an immune attack on hair follicles, influenced by genetics and environment.

Horse skin diseases are complex to manage and often require a biopsy for accurate diagnosis and treatment.

There is no cure for myotonic dystrophy type 1, so treatment focuses on managing symptoms and complications.

Baricitinib was effective and safe for severe hair loss treatment over 6 months.

Two drugs, ritlecitinib and brepocitinib, improved scalp hair loss condition markers.

Corticosteroid treatment reduces inflammation and alters hair keratins in alopecia areata.

Dupilumab treatment reduces Th2-related markers and helps hair growth in alopecia areata, showing Th2's role in the condition.

Intralesional triamcinolone injections can effectively stop frontal fibrosing alopecia with minimal side effects.

Healthy lifestyle changes can significantly improve skin health as you age.

Alopecia areata and vitiligo share immune system dysfunction but differ in specific immune responses and affected areas.

Scientists are still unsure what triggers the immune system to attack hair follicles in Alopecia areata.

The conclusion is that women are heavily affected by autoimmune skin diseases, face significant challenges, and need better research, treatments, and healthcare policies.

The document concludes that recognizing and treating cutaneous lupus erythematosus early is crucial for managing the skin and potential systemic symptoms.